Laila Nutra Private Limited
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Laila Nutraceuticals (to 2025)
7
Ending by 2030
Nov 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Synergistic herbal compositions for testosterone boosting (US 11,684,648) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Jan 25, 2027The maintenance fee for Odor masking formulations for natural compounds (US 11,707,499) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 1 fee due Feb 11, 2027The maintenance fee for Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts (US 9,101,599) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
- 1 fee due Apr 30, 2027The maintenance fee for Synergistic herbal compositions for the treatment of obesity and overweight (US 11,801,277) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
- 1 fee due May 12, 2027The maintenance fee for Composition from Sphaeranthus indicus and Garcinia mangostana for the control of metabolic syndrome (US 10,471,114) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 2 fees due Jul 26 to 28, 2027 · next Jul 26
- 1 fee due Aug 20, 2027The maintenance fee for Synergistic dietary supplement compositions for the prevention, treatment or control of inflammatory disorders (US 11,903,991) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
- 1 fee due Oct 5, 2027The maintenance fee for Anti-adipogenic compositions containing Piper betle and Dolichos biflorus (US 9,301,987) comes due Oct 5, 2027. Unpaid by Apr 5, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 22, 2026
- Oct 7 US 8,853,261 Nutraceutical Composition from Garcinia Mangostana · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,541,383 | Synergistic phytochemical composition for the treatment of obesity In force · USPTO record | In force | USPTO record | |
| US 9,301,987 | Anti-adipogenic compositions containing Piper betle and Dolichos biflorus In force · USPTO record | In force | USPTO record | |
| US 9,241,964 | Composition from Sphaeranthus indicus and Garcinia mangostana for the control of metabolic syndrome In force · USPTO record | In force | USPTO record | |
| US 11,426,438 | Method for treating arthritis with Boswellia serrata extracts In force · USPTO record | In force | USPTO record | |
| US 8,551,496 | Boswellia low polar gum resin extract and its synergistic compositions In force · USPTO record | In force | USPTO record | |
| US 10,206,964 | Synergistic anti-inflammatory compositions comprising Boswellia serrata extract In force · USPTO record | In force | USPTO record | |
| US 9,101,599 | Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts In force · USPTO record | In force | USPTO record | |
| US 8,828,377 | Boswellia oil, its fractions and compositions for enhancing brain function In force · USPTO record | In force | USPTO record | |
| US 9,795,646 | Boswellia oil, its fractions and compositions for enhancing brain function In force · USPTO record | In force | USPTO record | |
| US 10,105,347 | Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 30: 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.